XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ·Healthcare·Biotechnology
$2.30
-3.77%
Mkt Cap $956.38K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Dec 29, 2025 | — | — | — | — | -$0.36 | — | — | — |
| Q2 2025 Jun 30, 2025 | — | — | — | — | $0.10 | — | — | — |
| Q1 2025 Jan 1, 2025 | — | $289.00K | — | — | -$0.04 | — | — | — |
| Q4 2024 Dec 30, 2024 | — | $162.00K | — | — | -$0.13 | — | — | — |
| Q3 2024 Sep 26, 2024 | — | — | — | — | -$0.07 | — | — | — |
| Q2 2024 May 13, 2024 | — | — | — | — | $0.10 | — | — | — |
| Q1 2024 Mar 27, 2024 | — | — | — | — | -$0.14 | — | — | — |
| Q4 2023 Nov 15, 2023 | — | — | — | — | -$0.04 | — | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q2 2023 May 16, 2023 | — | — | — | — | -$0.17 | — | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | — | -$0.14 | — | — | — |
| Q4 2022 Nov 29, 2022 | — | — | — | — | -$0.15 | — | — | — |
| Q3 2022 Aug 24, 2022 | — | — | — | — | -$0.10 | — | — | — |
| Q2 2022 Jun 1, 2022 | — | — | — | — | $1.49 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | — | $0.40 | — | — | — |
| Q4 2021 Nov 24, 2021 | — | — | — | — | -$1.52 | — | — | — |
| Q3 2021 Aug 24, 2021 | — | — | — | — | -$0.22 | — | — | — |
| Q2 2021 May 19, 2021 | — | — | — | — | $0.05 | — | — | — |
| Q1 2021 Mar 15, 2021 | — | — | — | — | $0.04 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$1.84 | — | — | — |